APA (7th ed.) Citation

PJ, P., H, D., S, S., AH, R., G, W., RP, G., . . . J, N. (2017). Aflibercept treatment for neovascular AMD beyond the first year: Consensus recommendations by a UK expert roundtable panel, 2017 update. Clinical ophthalmology (Auckland, N.Z.), 11, 1957. https://doi.org/10.2147/OPTH.S145732

Chicago Style (17th ed.) Citation

PJ, Patel, et al. "Aflibercept Treatment for Neovascular AMD Beyond the First Year: Consensus Recommendations by a UK Expert Roundtable Panel, 2017 Update." Clinical Ophthalmology (Auckland, N.Z.) 11 (2017): 1957. https://doi.org/10.2147/OPTH.S145732.

MLA (9th ed.) Citation

PJ, Patel, et al. "Aflibercept Treatment for Neovascular AMD Beyond the First Year: Consensus Recommendations by a UK Expert Roundtable Panel, 2017 Update." Clinical Ophthalmology (Auckland, N.Z.), vol. 11, 2017, p. 1957, https://doi.org/10.2147/OPTH.S145732.